Proteotype Launches €3 Million European Study to Advance Multi-Cancer Detection and Evaluate Home Blood Collection

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

ProteotypeDiagnostic

More Like This

PR Newswire associated0

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

PR Newswire associated0

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

PR Newswire associated0

Proteotype Unveils Alchemi®, the Data and Orchestration Platform Behind Enlighten®

PR Newswire associated0

Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology

PR Newswire associated0

Innovative Immunodiagnostic Platform Unveils Highly Sensitive Cancer Early-Detection Test with Predictive Treatment Insights

Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer

Immunovia successfully completes discovery phase of next-generation test development

Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study